T4032
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T4032, covering 2023-11-21 to 2023-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients [Phase 3]